Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA)
Volume 66, Issues 2–3, February 2002, Pages 243-256
Regular ArticleEndocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy
References (145)
Cannabinoids and pain
Prog Neurobiol
(2001)- et al.
Biochemistry of the endogenous ligands of cannabinoid receptors
Neurobiol Dis
(1998) - et al.
Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat
FEBS Lett
(1996) - et al.
The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 agonist palmitoylethanolamide investigated in models of visceral and somatic inflammatory pain
Pain
(1998) - et al.
Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent
Eur J Pharmacol
(1993) - et al.
Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents
Pharmacol Biochem Behav
(1993) Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol
Prostaglandins Other Lipid Mediat
(2000)- et al.
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
Biochem Pharmacol
(1995) - et al.
2-Arachidonylglycerol and the cannabinoid receptor
Chem Phys Lipids
(2000) - et al.
Evidence that 2-arachidonoylglycerol but not N -palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells
J Biol Chem
(2000)
N -(2-Hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-regulating mast cell activation
Eur J Pharmacol
(1996)
Antinociceptive activity of the endogenous fatty acid amide, palmitoylethanolamide
Eur J Pharmacol
(2001)
An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity
Eur J Pharmacol
(1998)
Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders
Chem Phys Lipids
(2000)
Fatty acid amid hydrolase: biochemistry, pharmacology and therapeutic possibilities for an enzyme hydrolysing anandamide, 2-arachidonylglycerol, palmitoylethanolamide and oleamide
Biochem Pharmacol
(2001)
Cannabinoid receptor genes
Prog Neurobiol
(1996)
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Neuroscience
(1998)
Cannabinoid CB1 receptor expression in rat spinal cord
Mol Cell Neurosci
(2000)
Pre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord
Brain Res
(1999)
Localization of central cannabinoid CB l receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study
Neuroscience
(1999)
Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurones
Neuroscience
(2000)
Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system
Toxicol Appl Pharmacol
(1997)
Regulation of cannabinoid and mu opioid receptors in rat lumbar spinal cord following neonatal capsaicin treatment
Neurosci Lett
(1998)
Antihyperalgesic effects of spinal cannabinoids
Eur J Pharmacol
(1998)
Distribution of cannabinoid receptor messenger RNA in the human brain: an in situ hybridization histochemistry with oligonucleotides
Neurosci Lett
(1992)
Cannabinoid receptors undergo axonal flow in sensory nerves
Neuroscience
(1999)
Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception
Neuropharmacology
(2001)
Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals
Neuron
(2001)
Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto purkinje cells
Neuron
(2001)
Spinal mechanisms of delta 9-tetrahydrocannabinol-induced analgesia
Brain Res
(1992)
Cannabinoid transmission and pain perception
Neurobiol Dis
(1998)
Cannabinoid-induced antinociception is mediated by a spinal alpha 2-noradrenergic mechanism
Brain Res
(1991)
Spinal cannabinoids are anti-allodynic in rats with persistent inflammation
Pain
(1999)
Suppression of noxious stimulus-evoked expression of FOS protein-like immunoreactivity in rat spinal cord by a selective cannabinoid agonist
Neuroscience
(1996)
The role of central and peripheral cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain
Pain
(2001)
Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors
Pain
(1998)
Hyperalgesia due to nerve injury: role of neutrophils
Neuroscience
(2000)
Nerve growth factor regulates the expression of bradykinin binding sites on adult sensory neurons via the neurotrophin receptor p75
Neuroscience
(1998)
Local injection of nerve growth factor (NGF) triggers degranulation of mast cells in rat paw
Neurosci Lett
(1997)
Nerve growth factor: from neurotrophin to neurokine
Trends Neurosci
(1996)
Inhibition of nitric oxide production in RAW264. 7 macrophages by cannabinoids and palmitoylethanolamide
Eur J Pharmacol
(2000)
Cannabinoids and pain
Curr Opi Invest Drugs
(2001)
Analgesics: cannabinoids
2-arachidonyl glycerol ether, an endogenous agonist of the cannabinoid CB1 receptor
PNAS
(2001)
Isolation and structure of a brain constituent that binds to the cannabinoid receptor
Science
(1992)
Low doses of anandamides inhibit pharmacological effects of delta 9-tetrahydrocannabinol
J Pharmacol Exp Ther
(1995)
Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction
Proc Natl Acad Sci USA
(1993)
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
Nature
(1999)
The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)
Br J Pharmacol
(2000)
Cited by (0)
- f1
Correspondence to: Dr Andrew S. C. Rice, Department of Anaesthetics, Division of Surgery, Anaesthetics and Intensive Care, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Chelsea and Westminster Hospital Campus, 369 Fulham Road, London SW10 9NH, UK. Tel. GB+20-8746-8156; Fax: GB+20-8237-5109; E-mail: [email protected]
Copyright © 2002 Elsevier Science Ltd. All rights reserved.